Clinical trial
Study of Resynchronization and CABG Unified Efficacy in Ischemic Heart Failure Patients
NCT00846001 is registered in ClinicalTrials.gov with Meshalkin Research Institute of Pathology of Circulation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of Resynchronization and CABG Unified Efficacy in Ischemic Heart Failure Patients
- Lead sponsor
- Meshalkin Research Institute of Pathology of Circulation
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 30, 2007
- Completion date
- September 30, 2010
- Enrollment
- 178 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
ischemic heart failure